OUE Healthcare Warns of H1 2024 Loss
OUE Healthcare Warns of H1 2024 Loss
Startup costs and operating losses from its hospitals in China, the foreign exchange impact of a strong Singapore dollar, and higher financing costs from loans taken to fund the 2023 acquisition of Healthway Medical Corporation Limited's shares also affected the company's bottom line, according to their statement.One reason for the loss is the disposal of vacant land in Kuala Lumpur.
造成亏损的原因之一是在吉隆坡的空地处理。
OUE Healthcare expects a loss attributable to shareholders in H1 2024.
华联医疗预计2024年上半年归属股东的净亏损。
In a bourse filing, the company attributed its expected net loss to its one-off loss arising from the disposal of the vacant land in Kuala Lumpur, amongst others.
该公司在证交所的文件中称，其预计净亏损归咎于吉隆坡空地处理等一次性亏损。
Startup costs and operating losses from its hospitals in China, the foreign exchange impact of a strong Singapore dollar, and higher financing costs from loans taken to fund the 2023 acquisition of Healthway Medical Corporation Limited's shares also affected the company's bottom line, according to their statement.
根据公司的声明，机构成本和中国医院的运营亏损，新加坡元强劲对外汇的影响，以及为了资助2023年收购医道医疗股份而贷款导致的更高融资成本也影响了公司的底线。
The company is finalising its unaudited financial results for the period and will release it on or before 14 August.
公司正在完成将在期间未经审计的财务结果，并将在8月14日或之前发布。
In the meantime, the company advised its shareholders and potential investors to exercise caution when dealing with its shares.
与股票交易有关的华联医疗股东和潜在投资者暂时应谨慎处理。
